Research Topics

Genomes and Genes

Species

Ming Qing Xu

Summary

Country: China

Publications

  1. Xu L, Zhou X, Yi P, Zhang M, Li J, Xu M. Alvimopan combined with enhanced recovery strategy for managing postoperative ileus after open abdominal surgery: a systematic review and meta-analysis. J Surg Res. 2016;203:211-21 pubmed publisher
    ....
  2. Xu L, Zhang M, Zheng X, Yi P, Lan C, Xu M. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2017;143:17-27 pubmed publisher
    ..Especially, ciRS-7 was one of the independent factors of hepatic MVI. These data suggested that ciRS-7 may be a promising biomarker of hepatic MVI and a novel therapy target for restraining MVI. ..
  3. Chen X, Zheng X, Cai Z, Lin X, Xu M. MicroRNA-203 promotes liver regeneration after partial hepatectomy in cirrhotic rats. J Surg Res. 2017;211:53-63 pubmed publisher
    ..Together with the tumor suppressive effect on HCC, miR-203 would be an ideal candidate for promoting liver regeneration in HCC patients undergoing liver resection without the risk of tumorigenesis or cancer recurrence. ..
  4. Xu L, Zhang M, Yi P, Zheng X, Feng L, Lan C, et al. Hepatic resection combined with radiofrequency ablation versus hepatic resection alone for multifocal hepatocellular carcinomas: A meta-analysis. J Huazhong Univ Sci Technolog Med Sci. 2017;37:974-980 pubmed publisher
    ..And this therapy may be a promising alternative for these patients with marginal liver function or complicated tumor distribution. Furthermore, high quality randomized controlled trials (RCTs) are imperative to verify this conclusion. ..
  5. Xu M, Suo Y, Gong J, Zhang M, Yan L. Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides. World J Gastroenterol. 2004;10:2361-8 pubmed
    ....
  6. request reprint
    Chen X, Xu M. Primary graft dysfunction after liver transplantation. Hepatobiliary Pancreat Dis Int. 2014;13:125-37 pubmed
    ..Additionally, numerous factors affect the allograft function after transplantation, making the prediction of PGD more difficult. The present review was to analyze the literature available on PGD and to propose a definition...
  7. request reprint
    Yi P, Zhang M, Xu M. Role of microRNA in liver regeneration. Hepatobiliary Pancreat Dis Int. 2016;15:141-6 pubmed
    ..Blocking or stimulating the pathways of miRNAs in liver regeneration may be novel therapeutic strategies in future regeneration-related liver managements. We may discover additional chemotherapy targets of miRNA. ..

Locale

Detail Information

Publications7

  1. Xu L, Zhou X, Yi P, Zhang M, Li J, Xu M. Alvimopan combined with enhanced recovery strategy for managing postoperative ileus after open abdominal surgery: a systematic review and meta-analysis. J Surg Res. 2016;203:211-21 pubmed publisher
    ....
  2. Xu L, Zhang M, Zheng X, Yi P, Lan C, Xu M. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2017;143:17-27 pubmed publisher
    ..Especially, ciRS-7 was one of the independent factors of hepatic MVI. These data suggested that ciRS-7 may be a promising biomarker of hepatic MVI and a novel therapy target for restraining MVI. ..
  3. Chen X, Zheng X, Cai Z, Lin X, Xu M. MicroRNA-203 promotes liver regeneration after partial hepatectomy in cirrhotic rats. J Surg Res. 2017;211:53-63 pubmed publisher
    ..Together with the tumor suppressive effect on HCC, miR-203 would be an ideal candidate for promoting liver regeneration in HCC patients undergoing liver resection without the risk of tumorigenesis or cancer recurrence. ..
  4. Xu L, Zhang M, Yi P, Zheng X, Feng L, Lan C, et al. Hepatic resection combined with radiofrequency ablation versus hepatic resection alone for multifocal hepatocellular carcinomas: A meta-analysis. J Huazhong Univ Sci Technolog Med Sci. 2017;37:974-980 pubmed publisher
    ..And this therapy may be a promising alternative for these patients with marginal liver function or complicated tumor distribution. Furthermore, high quality randomized controlled trials (RCTs) are imperative to verify this conclusion. ..
  5. Xu M, Suo Y, Gong J, Zhang M, Yan L. Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides. World J Gastroenterol. 2004;10:2361-8 pubmed
    ....
  6. request reprint
    Chen X, Xu M. Primary graft dysfunction after liver transplantation. Hepatobiliary Pancreat Dis Int. 2014;13:125-37 pubmed
    ..Additionally, numerous factors affect the allograft function after transplantation, making the prediction of PGD more difficult. The present review was to analyze the literature available on PGD and to propose a definition...
  7. request reprint
    Yi P, Zhang M, Xu M. Role of microRNA in liver regeneration. Hepatobiliary Pancreat Dis Int. 2016;15:141-6 pubmed
    ..Blocking or stimulating the pathways of miRNAs in liver regeneration may be novel therapeutic strategies in future regeneration-related liver managements. We may discover additional chemotherapy targets of miRNA. ..